Aarey Drugs & Pharmaceuticals Limited (BOM:524412)

India flag India · Delayed Price · Currency is INR
70.40
+2.96 (4.39%)
At close: Feb 12, 2026
Market Cap1.91B +45.5%
Revenue (ttm)3.95B -32.2%
Net Income34.35M -39.8%
EPS1.20 -42.5%
Shares Out28.45M
PE Ratio56.16
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,398
Average Volume6,248
Open66.01
Previous Close67.44
Day's Range66.01 - 70.95
52-Week Range31.30 - 100.00
Beta0.53
RSI49.36
Earnings DateFeb 11, 2026

About BOM:524412

Aarey Drugs & Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients, intermediates, and specialty chemicals for various industrial applications in India. The company offers intermediates, including mono methyl urea, di methyl urea, ortho para nitro anisole, 2-bromomethyl-1,3-dioxolane, and uracil. It also provides active pharmaceutical ingredients, such as metformin HCl, mefenamic acid, and doxofylline. In addition, the company trades chemicals and solvents, including aromatic chemicals, chemical acids, chlor-alkali, ... [Read more]

Industry Medicinal Chemicals and Botanical Products
Founded 1990
Employees 132
Stock Exchange Bombay Stock Exchange
Ticker Symbol 524412
Full Company Profile

Financial Performance

In fiscal year 2025, BOM:524412's revenue was 4.74 billion, an increase of 17.73% compared to the previous year's 4.03 billion. Earnings were 40.24 million, a decrease of -14.09%.

Financial Statements